Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08WQM
|
||||
Former ID |
DNC002796
|
||||
Drug Name |
O-Sialic Acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551374] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H19NO9
|
||||
Canonical SMILES |
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)O)O
|
||||
InChI |
1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11?/m0/s1
|
||||
InChIKey |
SQVRNKJHWKZAKO-LUWBGTNYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | P-selectin | Target Info | Inhibitor | [551374] | |
Neuraminidase | Target Info | Inhibitor | [551374] | ||
E-selectin | Target Info | Inhibitor | [551374] | ||
Liver carboxylesterase | Target Info | Inhibitor | [551374] | ||
WikiPathways | Human Complement System | ||||
Spinal Cord Injury | |||||
Cell surface interactions at the vascular wallWP2806:Human Complement System | |||||
TNF alpha Signaling Pathway | |||||
Cell surface interactions at the vascular wallWP2884:NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Heroin metabolism | |||||
Irinotecan Pathway | |||||
Fluoropyrimidine Activity | |||||
Phase I biotransformations, non P450 | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.